fanta.bio Sample: CNhs10878
- Species
- human
- CRE Type
- ELA
- Cluster
- 0
- Cell Type Class
- Cardiovascular
18034 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX19538267 | U2OS Bone | 411 / 9743 (4.2%) | 78 / 97430 (0.1%) | −324.0 | −324.0 | 52.69 |
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1236 / 9743 (12.7%) | 239 / 97430 (0.2%) | −324.0 | −324.0 | 51.72 |
| TP53 SRX19538274 | U2OS Bone | 459 / 9743 (4.7%) | 90 / 97430 (0.1%) | −324.0 | −324.0 | 51.00 |
| TP53 SRX19538276 | U2OS Bone | 457 / 9743 (4.7%) | 95 / 97430 (0.1%) | −324.0 | −324.0 | 48.11 |
| TP53 SRX19538268 | U2OS Bone | 464 / 9743 (4.8%) | 100 / 97430 (0.1%) | −324.0 | −324.0 | 46.40 |
| TP53 SRX19538275 | U2OS Bone | 407 / 9743 (4.2%) | 95 / 97430 (0.1%) | −324.0 | −324.0 | 42.84 |
| TP53 SRX19538279 | Osteoblasts Bone | 563 / 9743 (5.8%) | 136 / 97430 (0.1%) | −324.0 | −324.0 | 41.40 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1740 / 9743 (17.9%) | 421 / 97430 (0.4%) | −324.0 | −324.0 | 41.33 |
| TP53 SRX19538280 | Osteoblasts Bone | 445 / 9743 (4.6%) | 110 / 97430 (0.1%) | −324.0 | −324.0 | 40.45 |
| HIF1A SRX11007095 | HK-2 Kidney | 2210 / 9743 (22.7%) | 556 / 97430 (0.6%) | −324.0 | −324.0 | 39.75 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1718 / 9743 (17.6%) | 439 / 97430 (0.5%) | −324.0 | −324.0 | 39.13 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 452 / 9743 (4.6%) | 117 / 97430 (0.1%) | −324.0 | −324.0 | 38.63 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 2274 / 9743 (23.3%) | 673 / 97430 (0.7%) | −324.0 | −324.0 | 33.79 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 2322 / 9743 (23.8%) | 695 / 97430 (0.7%) | −324.0 | −324.0 | 33.41 |
| SCML2 SRX644728 | 293 Kidney | 1391 / 9743 (14.3%) | 445 / 97430 (0.5%) | −324.0 | −324.0 | 31.26 |
| TP53 SRX19538281 | Osteoblasts Bone | 473 / 9743 (4.9%) | 160 / 97430 (0.2%) | −324.0 | −324.0 | 29.56 |
| HIF1A SRX20663235 | HK-2 Kidney | 462 / 9743 (4.7%) | 164 / 97430 (0.2%) | −324.0 | −324.0 | 28.17 |
| FOXP1 SRX736067 | LNCAP Prostate | 1709 / 9743 (17.5%) | 654 / 97430 (0.7%) | −324.0 | −324.0 | 26.13 |
| TP53 SRX19538269 | U2OS Bone | 494 / 9743 (5.1%) | 228 / 97430 (0.2%) | −324.0 | −324.0 | 21.67 |
| MYH11 SRX265221 | ME-1 Blood | 806 / 9743 (8.3%) | 372 / 97430 (0.4%) | −324.0 | −324.0 | 21.67 |
| MED1 SRX9419945 | BT-474 Breast | 2728 / 9743 (28.0%) | 1821 / 97430 (1.9%) | −324.0 | −324.0 | 14.98 |
| MED1 SRX9419944 | BT-474 Breast | 2689 / 9743 (27.6%) | 1797 / 97430 (1.8%) | −324.0 | −324.0 | 14.96 |
| BRD4 SRX9419935 | BT-474 Breast | 2708 / 9743 (27.8%) | 1841 / 97430 (1.9%) | −324.0 | −324.0 | 14.71 |
| BRD4 SRX9419937 | BT-474 Breast | 2737 / 9743 (28.1%) | 1878 / 97430 (1.9%) | −324.0 | −324.0 | 14.57 |
| MED1 SRX9419946 | BT-474 Breast | 2780 / 9743 (28.5%) | 1908 / 97430 (2.0%) | −324.0 | −324.0 | 14.57 |
| BRD4 SRX9419936 | BT-474 Breast | 2772 / 9743 (28.5%) | 1917 / 97430 (2.0%) | −324.0 | −324.0 | 14.46 |
| MED1 SRX9419947 | BT-474 Breast | 2696 / 9743 (27.7%) | 1878 / 97430 (1.9%) | −324.0 | −324.0 | 14.36 |
| BRD4 SRX9419938 | BT-474 Breast | 2712 / 9743 (27.8%) | 1940 / 97430 (2.0%) | −324.0 | −324.0 | 13.98 |
| BRD4 SRX736201 | 90-8TL Neural | 4959 / 9743 (50.9%) | 4038 / 97430 (4.1%) | −324.0 | −324.0 | 12.28 |
| EZH2 SRX2146136 | LNCAP Prostate | 5930 / 9743 (60.9%) | 4992 / 97430 (5.1%) | −324.0 | −324.0 | 11.88 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1481 / 9743 (15.2%) | 1606 / 97430 (1.6%) | −324.0 | −324.0 | 9.22 |
| TP53 SRX19538273 | U2OS Bone | 396 / 9743 (4.1%) | 84 / 97430 (0.1%) | −323.3 | −320.3 | 47.14 |
| TP53 SRX19538270 | U2OS Bone | 473 / 9743 (4.9%) | 225 / 97430 (0.2%) | −317.0 | −314.0 | 21.02 |
| TP53 SRX19538271 | U2OS Bone | 630 / 9743 (6.5%) | 702 / 97430 (0.7%) | −293.1 | −290.2 | 8.97 |
| IRF3 SRX11453858 | Hep G2 Liver | 334 / 9743 (3.4%) | 51 / 97430 (0.1%) | −288.0 | −285.0 | 65.49 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 792 / 9743 (8.1%) | 1309 / 97430 (1.3%) | −285.3 | −282.3 | 6.05 |
| TP53 SRX19538282 | Osteoblasts Bone | 404 / 9743 (4.1%) | 164 / 97430 (0.2%) | −283.8 | −280.8 | 24.63 |
| BRD4 SRX736204 | 90-8TL Neural | 854 / 9743 (8.8%) | 1610 / 97430 (1.7%) | −277.3 | −274.3 | 5.30 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 534 / 9743 (5.5%) | 528 / 97430 (0.5%) | −264.6 | −261.7 | 10.11 |
| IRF3 SRX11453861 | Hep G2 Liver | 291 / 9743 (3.0%) | 43 / 97430 (0.0%) | −252.0 | −249.1 | 67.67 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 970 / 9743 (10.0%) | 2361 / 97430 (2.4%) | −248.4 | −245.5 | 4.11 |
| AR SRX10820653 | LNCAP Prostate | 336 / 9743 (3.4%) | 117 / 97430 (0.1%) | −245.9 | −243.0 | 28.72 |
| PBX4 SRX2731658 | PC-3 Prostate | 447 / 9743 (4.6%) | 15146 / 97430 (15.5%) | −239.0 | −236.1 | 0.30 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 904 / 9743 (9.3%) | 2197 / 97430 (2.3%) | −231.2 | −228.4 | 4.11 |
| TP53 SRX19538272 | U2OS Bone | 520 / 9743 (5.3%) | 655 / 97430 (0.7%) | −224.2 | −221.3 | 7.94 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 495 / 9743 (5.1%) | 615 / 97430 (0.6%) | −215.1 | −212.2 | 8.05 |
| AR SRX10820651 | LNCAP Prostate | 331 / 9743 (3.4%) | 177 / 97430 (0.2%) | −212.8 | −210.0 | 18.70 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 261 / 9743 (2.7%) | 70 / 97430 (0.1%) | −203.1 | −200.3 | 37.29 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 458 / 9743 (4.7%) | 569 / 97430 (0.6%) | −198.8 | −196.0 | 8.05 |
| KAT6A SRX20971022 | Fibroblasts Others | 242 / 9743 (2.5%) | 51 / 97430 (0.1%) | −197.7 | −194.8 | 47.45 |
| AGO2 SRX4708039 | Hep G2 Liver | 1231 / 9743 (12.6%) | 4381 / 97430 (4.5%) | −196.5 | −193.7 | 2.81 |
| BMI1 SRX644729 | 293 Kidney | 246 / 9743 (2.5%) | 69 / 97430 (0.1%) | −189.5 | −186.7 | 35.65 |
| YAP1 SRX757325 | H2052 Lung | 328 / 9743 (3.4%) | 11706 / 97430 (12.0%) | −189.4 | −186.7 | 0.28 |
| FOS SRX150477 | MCF 10A Breast | 316 / 9743 (3.2%) | 11332 / 97430 (11.6%) | −183.8 | −181.0 | 0.28 |
| STAT5B SRX831881 | CD8+ T cells Blood | 248 / 9743 (2.5%) | 88 / 97430 (0.1%) | −180.5 | −177.7 | 28.18 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 957 / 9743 (9.8%) | 3096 / 97430 (3.2%) | −173.4 | −170.6 | 3.09 |
| YAP1 SRX757326 | H2052 Lung | 284 / 9743 (2.9%) | 10473 / 97430 (10.7%) | −173.3 | −170.5 | 0.27 |
| FOS SRX150478 | MCF 10A Breast | 351 / 9743 (3.6%) | 11575 / 97430 (11.9%) | −172.8 | −170.0 | 0.30 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 305 / 9743 (3.1%) | 10808 / 97430 (11.1%) | −172.7 | −169.9 | 0.28 |
| Epitope tags SRX10549776 | K-562 Blood | 937 / 9743 (9.6%) | 2995 / 97430 (3.1%) | −172.4 | −169.7 | 3.13 |
| FOXA1 SRX4815198 | MCF-7 Breast | 511 / 9743 (5.2%) | 14061 / 97430 (14.4%) | −172.2 | −169.5 | 0.36 |
| 5-mC SRX882970 | LNCAP Prostate | 1828 / 9743 (18.8%) | 8850 / 97430 (9.1%) | −169.3 | −166.6 | 2.07 |
| NFYB SRX16608147 | HeLa Uterus | 246 / 9743 (2.5%) | 109 / 97430 (0.1%) | −168.1 | −165.3 | 22.57 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 367 / 9743 (3.8%) | 419 / 97430 (0.4%) | −167.3 | −164.6 | 8.76 |
| 5-mC SRX882968 | LNCAP Prostate | 1812 / 9743 (18.6%) | 8831 / 97430 (9.1%) | −165.1 | −162.4 | 2.05 |
| FOXA1 SRX4815197 | MCF-7 Breast | 363 / 9743 (3.7%) | 11486 / 97430 (11.8%) | −163.7 | −161.0 | 0.32 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 458 / 9743 (4.7%) | 822 / 97430 (0.8%) | −152.9 | −150.2 | 5.57 |
| ESR1 SRX7624157 | MCF-7 Breast | 419 / 9743 (4.3%) | 11968 / 97430 (12.3%) | −151.4 | −148.7 | 0.35 |
| FOXA1 SRX176862 | MCF-7 Breast | 183 / 9743 (1.9%) | 8017 / 97430 (8.2%) | −151.0 | −148.3 | 0.23 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 457 / 9743 (4.7%) | 834 / 97430 (0.9%) | −150.5 | −147.8 | 5.48 |
| CDK9 SRX7366781 | MCF-7 Breast | 210 / 9743 (2.2%) | 84 / 97430 (0.1%) | −147.9 | −145.2 | 25.00 |
| 5-mC SRX882965 | LNCAP Prostate | 1480 / 9743 (15.2%) | 6887 / 97430 (7.1%) | −146.4 | −143.7 | 2.15 |
| ESR1 SRX371478 | MCF-7 Breast | 183 / 9743 (1.9%) | 7874 / 97430 (8.1%) | −146.1 | −143.5 | 0.23 |
| FOS SRX4192880 | MCF 10A Breast | 258 / 9743 (2.6%) | 9098 / 97430 (9.3%) | −142.8 | −140.1 | 0.28 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 573 / 9743 (5.9%) | 13956 / 97430 (14.3%) | −142.7 | −140.0 | 0.41 |
| GATA3 SRX190239 | MCF-7 Breast | 226 / 9743 (2.3%) | 8506 / 97430 (8.7%) | −141.5 | −138.9 | 0.27 |
| ESR1 SRX4367193 | MCF-7 Breast | 558 / 9743 (5.7%) | 13693 / 97430 (14.1%) | −141.3 | −138.7 | 0.41 |
| ESR1 SRX20282961 | MCF-7 Breast | 188 / 9743 (1.9%) | 7821 / 97430 (8.0%) | −141.3 | −138.6 | 0.24 |
| CDK9 SRX7366783 | MCF-7 Breast | 209 / 9743 (2.1%) | 96 / 97430 (0.1%) | −141.2 | −138.6 | 21.77 |
| FOXA1 SRX1161177 | MCF-7 Breast | 142 / 9743 (1.5%) | 6956 / 97430 (7.1%) | −141.2 | −138.6 | 0.20 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 344 / 9743 (3.5%) | 467 / 97430 (0.5%) | −140.8 | −138.2 | 7.37 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 268 / 9743 (2.8%) | 9193 / 97430 (9.4%) | −140.6 | −138.0 | 0.29 |
| FOXA1 SRX176863 | MCF-7 Breast | 179 / 9743 (1.8%) | 7609 / 97430 (7.8%) | −139.7 | −137.1 | 0.24 |
| SOX2 SRX2731713 | Lung cancer cell line Lung | 189 / 9743 (1.9%) | 64 / 97430 (0.1%) | −139.2 | −136.6 | 29.53 |
| ESR1 SRX371469 | MCF-7 Breast | 150 / 9743 (1.5%) | 7053 / 97430 (7.2%) | −139.1 | −136.5 | 0.21 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 97 / 9743 (1.0%) | 5947 / 97430 (6.1%) | −137.7 | −135.1 | 0.16 |
| FOXA1 SRX3931044 | MCF-7 Breast | 360 / 9743 (3.7%) | 10583 / 97430 (10.9%) | −137.3 | −134.7 | 0.34 |
| ESR1 SRX7624156 | MCF-7 Breast | 261 / 9743 (2.7%) | 8965 / 97430 (9.2%) | −137.0 | −134.4 | 0.29 |
| FOXA1 SRX371482 | MCF-7 Breast | 234 / 9743 (2.4%) | 8463 / 97430 (8.7%) | −135.6 | −133.0 | 0.28 |
| TLE3 SRX4815191 | MCF-7 Breast | 138 / 9743 (1.4%) | 6707 / 97430 (6.9%) | −135.2 | −132.6 | 0.21 |
| CEBPB SRX150632 | HeLa Uterus | 374 / 9743 (3.8%) | 10725 / 97430 (11.0%) | −135.1 | −132.6 | 0.35 |
| YAP1 SRX5718140 | 293 Kidney | 266 / 9743 (2.7%) | 8984 / 97430 (9.2%) | −135.0 | −132.4 | 0.30 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 178 / 9743 (1.8%) | 7440 / 97430 (7.6%) | −134.6 | −132.0 | 0.24 |
| ESR1 SRX176860 | MCF-7 Breast | 272 / 9743 (2.8%) | 9048 / 97430 (9.3%) | −133.8 | −131.2 | 0.30 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 138 / 9743 (1.4%) | 6652 / 97430 (6.8%) | −133.3 | −130.7 | 0.21 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 180 / 9743 (1.8%) | 7433 / 97430 (7.6%) | −133.1 | −130.5 | 0.24 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 232 / 9743 (2.4%) | 8345 / 97430 (8.6%) | −133.0 | −130.4 | 0.28 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 404 / 9743 (4.1%) | 11110 / 97430 (11.4%) | −132.9 | −130.4 | 0.36 |
| ESR1 SRX371479 | MCF-7 Breast | 132 / 9743 (1.4%) | 6506 / 97430 (6.7%) | −132.3 | −129.8 | 0.20 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 414 / 9743 (4.2%) | 11242 / 97430 (11.5%) | −132.2 | −129.7 | 0.37 |
| FOXA1 SRX371483 | MCF-7 Breast | 178 / 9743 (1.8%) | 7369 / 97430 (7.6%) | −132.1 | −129.6 | 0.24 |
| FOXA1 SRX371481 | MCF-7 Breast | 164 / 9743 (1.7%) | 7067 / 97430 (7.3%) | −130.6 | −128.1 | 0.23 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 405 / 9743 (4.2%) | 11047 / 97430 (11.3%) | −130.5 | −128.0 | 0.37 |
| ESR1 SRX371476 | MCF-7 Breast | 102 / 9743 (1.0%) | 5852 / 97430 (6.0%) | −130.4 | −127.9 | 0.17 |
| ESR1 SRX371471 | ZR-75-1 Breast | 167 / 9743 (1.7%) | 7114 / 97430 (7.3%) | −130.4 | −127.9 | 0.23 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 326 / 9743 (3.3%) | 9800 / 97430 (10.1%) | −130.0 | −127.5 | 0.33 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 233 / 9743 (2.4%) | 8258 / 97430 (8.5%) | −129.6 | −127.1 | 0.28 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 379 / 9743 (3.9%) | 660 / 97430 (0.7%) | −129.5 | −127.0 | 5.74 |
| SSRP1 SRX3436567 | HT-1080 Bone | 286 / 9743 (2.9%) | 332 / 97430 (0.3%) | −129.0 | −126.6 | 8.61 |
| ESR1 SRX1531791 | MCF-7 Breast | 150 / 9743 (1.5%) | 6735 / 97430 (6.9%) | −128.3 | −125.8 | 0.22 |
| ESR1 SRX20282960 | MCF-7 Breast | 188 / 9743 (1.9%) | 7419 / 97430 (7.6%) | −127.8 | −125.3 | 0.25 |
| FOS SRX150517 | MCF 10A Breast | 287 / 9743 (2.9%) | 9085 / 97430 (9.3%) | −127.3 | −124.8 | 0.32 |
| ESR1 SRX371470 | ZR-75-1 Breast | 137 / 9743 (1.4%) | 6454 / 97430 (6.6%) | −127.0 | −124.6 | 0.21 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 388 / 9743 (4.0%) | 10648 / 97430 (10.9%) | −126.6 | −124.1 | 0.36 |
| ESR1 SRX194572 | MCF-7 Breast | 85 / 9743 (0.9%) | 5386 / 97430 (5.5%) | −126.4 | −123.9 | 0.16 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 601 / 9743 (6.2%) | 13751 / 97430 (14.1%) | −126.3 | −123.9 | 0.44 |
| ESR1 SRX194569 | MCF-7 Breast | 165 / 9743 (1.7%) | 6952 / 97430 (7.1%) | −126.2 | −123.7 | 0.24 |
| FOXA1 SRX1161176 | MCF-7 Breast | 153 / 9743 (1.6%) | 6699 / 97430 (6.9%) | −125.0 | −122.6 | 0.23 |
| SS18 SRX3468047 | Fibroblasts Others | 455 / 9743 (4.7%) | 11591 / 97430 (11.9%) | −124.7 | −122.2 | 0.39 |
| ESR1 SRX176861 | MCF-7 Breast | 290 / 9743 (3.0%) | 9045 / 97430 (9.3%) | −124.6 | −122.2 | 0.32 |
| SMARCA2 SRX8119677 | MeT-5A Others | 273 / 9743 (2.8%) | 8749 / 97430 (9.0%) | −124.0 | −121.5 | 0.31 |
| ESR1 SRX371467 | MCF-7 Breast | 171 / 9743 (1.8%) | 6982 / 97430 (7.2%) | −123.5 | −121.0 | 0.24 |
| ESR1 SRX20282939 | MCF-7 Breast | 197 / 9743 (2.0%) | 7416 / 97430 (7.6%) | −122.5 | −120.1 | 0.27 |
| FOXA1 SRX1161173 | MCF-7 Breast | 124 / 9743 (1.3%) | 6072 / 97430 (6.2%) | −122.5 | −120.0 | 0.20 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 159 / 9743 (1.6%) | 6726 / 97430 (6.9%) | −122.3 | −119.9 | 0.24 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 216 / 9743 (2.2%) | 7720 / 97430 (7.9%) | −121.7 | −119.3 | 0.28 |
| JUNB SRX8488088 | SUM 229PE Breast | 341 / 9743 (3.5%) | 9750 / 97430 (10.0%) | −121.5 | −119.1 | 0.35 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 215 / 9743 (2.2%) | 7680 / 97430 (7.9%) | −121.0 | −118.6 | 0.28 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 140 / 9743 (1.4%) | 6331 / 97430 (6.5%) | −120.8 | −118.4 | 0.22 |
| ESR1 SRX371468 | MCF-7 Breast | 93 / 9743 (1.0%) | 5399 / 97430 (5.5%) | −120.8 | −118.4 | 0.17 |
| TCF12 SRX190356 | SK-N-SH Neural | 499 / 9743 (5.1%) | 12081 / 97430 (12.4%) | −120.6 | −118.2 | 0.41 |
| GATA3 SRX190194 | SK-N-SH Neural | 426 / 9743 (4.4%) | 11009 / 97430 (11.3%) | −120.5 | −118.1 | 0.39 |
| FOXA1 SRX100454 | T-47D Breast | 219 / 9743 (2.2%) | 7733 / 97430 (7.9%) | −120.4 | −118.0 | 0.28 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 355 / 9743 (3.6%) | 625 / 97430 (0.6%) | −120.2 | −117.8 | 5.68 |
| ESR1 SRX20282954 | MCF-7 Breast | 186 / 9743 (1.9%) | 7126 / 97430 (7.3%) | −119.4 | −117.0 | 0.26 |
| SMARCA4 SRX5212362 | Mel270 Others | 305 / 9743 (3.1%) | 9112 / 97430 (9.4%) | −119.4 | −117.0 | 0.33 |
| ESR1 SRX371477 | MCF-7 Breast | 61 / 9743 (0.6%) | 4665 / 97430 (4.8%) | −119.4 | −117.0 | 0.13 |
| FOS SRX150476 | MCF 10A Breast | 305 / 9743 (3.1%) | 9114 / 97430 (9.4%) | −119.4 | −117.0 | 0.33 |
| AR SRX1067070 | LHSAR Prostate | 447 / 9743 (4.6%) | 11279 / 97430 (11.6%) | −119.4 | −117.0 | 0.40 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 413 / 9743 (4.2%) | 10765 / 97430 (11.0%) | −119.0 | −116.6 | 0.38 |
| RELA SRX2207673 | HUVEC Cardiovascular | 693 / 9743 (7.1%) | 14738 / 97430 (15.1%) | −119.0 | −116.6 | 0.47 |
| AR SRX1067071 | LHSAR Prostate | 353 / 9743 (3.6%) | 9850 / 97430 (10.1%) | −119.0 | −116.6 | 0.36 |
| AGO2 SRX6783958 | Hep G2 Liver | 745 / 9743 (7.6%) | 2610 / 97430 (2.7%) | −118.8 | −116.4 | 2.85 |
| GATA3 SRX176864 | MCF-7 Breast | 114 / 9743 (1.2%) | 5754 / 97430 (5.9%) | −118.3 | −116.0 | 0.20 |
| ATF1 SRX11470446 | Mesenchymal stem cells Others | 462 / 9743 (4.7%) | 11451 / 97430 (11.8%) | −118.0 | −115.7 | 0.40 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 301 / 9743 (3.1%) | 9003 / 97430 (9.2%) | −118.0 | −115.6 | 0.33 |
| RUNX1 SRX2513054 | 293 Kidney | 1867 / 9743 (19.2%) | 10468 / 97430 (10.7%) | −117.8 | −115.5 | 1.78 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 149 / 9743 (1.5%) | 6403 / 97430 (6.6%) | −117.6 | −115.3 | 0.23 |
| FOXA1 SRX100506 | Hep G2 Liver | 228 / 9743 (2.3%) | 7790 / 97430 (8.0%) | −117.5 | −115.2 | 0.29 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 601 / 9743 (6.2%) | 13406 / 97430 (13.8%) | −117.3 | −115.0 | 0.45 |
| SMARCA4 SRX5212366 | Mel270 Others | 231 / 9743 (2.4%) | 7837 / 97430 (8.0%) | −117.3 | −114.9 | 0.29 |
| ARID1A SRX5089376 | MCF-7 Breast | 139 / 9743 (1.4%) | 6204 / 97430 (6.4%) | −117.2 | −114.8 | 0.22 |
| ETS1 SRX3033231 | HEYA8 Gonad | 226 / 9743 (2.3%) | 203 / 97430 (0.2%) | −117.1 | −114.8 | 11.13 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 152 / 9743 (1.6%) | 6437 / 97430 (6.6%) | −116.9 | −114.6 | 0.24 |
| ARID5B SRX3230377 | Hep G2 Liver | 465 / 9743 (4.8%) | 11458 / 97430 (11.8%) | −116.9 | −114.6 | 0.41 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 389 / 9743 (4.0%) | 10320 / 97430 (10.6%) | −116.7 | −114.4 | 0.38 |
| Epitope tags SRX392692 | T3M-1 Cl-10 Others | 156 / 9743 (1.6%) | 50 / 97430 (0.1%) | −116.6 | −114.3 | 31.20 |
| AGO2 SRX6783957 | Hep G2 Liver | 748 / 9743 (7.7%) | 2661 / 97430 (2.7%) | −116.6 | −114.2 | 2.81 |
| ESR1 SRX20282972 | MCF-7 Breast | 199 / 9743 (2.0%) | 7252 / 97430 (7.4%) | −116.1 | −113.8 | 0.27 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 300 / 9743 (3.1%) | 8919 / 97430 (9.2%) | −116.0 | −113.7 | 0.34 |
| Epitope tags SRX5877912 | U2OS Bone | 1108 / 9743 (11.4%) | 19994 / 97430 (20.5%) | −115.9 | −113.6 | 0.55 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 147 / 9743 (1.5%) | 6308 / 97430 (6.5%) | −115.8 | −113.5 | 0.23 |
| NANOG SRX20532160 | hESC HUES8 Pluripotent stem cell | 563 / 9743 (5.8%) | 12795 / 97430 (13.1%) | −115.3 | −113.0 | 0.44 |
| ESR1 SRX2943591 | MCF-7 Breast | 105 / 9743 (1.1%) | 5472 / 97430 (5.6%) | −114.7 | −112.4 | 0.19 |
| Epitope tags SRX392691 | T3M-1 Cl-10 Others | 157 / 9743 (1.6%) | 55 / 97430 (0.1%) | −114.7 | −112.4 | 28.55 |
| RELA SRX2207672 | HUVEC Cardiovascular | 754 / 9743 (7.7%) | 15379 / 97430 (15.8%) | −114.6 | −112.3 | 0.49 |
| FOXA2 SRX3230382 | Hep G2 Liver | 243 / 9743 (2.5%) | 7948 / 97430 (8.2%) | −114.5 | −112.2 | 0.31 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 235 / 9743 (2.4%) | 7805 / 97430 (8.0%) | −114.3 | −112.0 | 0.30 |
| FOXA1 SRX1161175 | MCF-7 Breast | 124 / 9743 (1.3%) | 5825 / 97430 (6.0%) | −114.0 | −111.7 | 0.21 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 129 / 9743 (1.3%) | 5914 / 97430 (6.1%) | −113.8 | −111.5 | 0.22 |
| FOXA1 SRX371480 | MCF-7 Breast | 106 / 9743 (1.1%) | 5459 / 97430 (5.6%) | −113.5 | −111.2 | 0.19 |
| ESR1 SRX10365535 | MCF-7 Breast | 137 / 9743 (1.4%) | 6055 / 97430 (6.2%) | −113.5 | −111.2 | 0.23 |
| NANOG SRX20532161 | hESC HUES8 Pluripotent stem cell | 500 / 9743 (5.1%) | 11829 / 97430 (12.1%) | −113.4 | −111.1 | 0.42 |
| GATA3 SRX5057632 | MCF-7 Breast | 106 / 9743 (1.1%) | 5445 / 97430 (5.6%) | −113.0 | −110.8 | 0.19 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 113 / 9743 (1.2%) | 5577 / 97430 (5.7%) | −112.9 | −110.6 | 0.20 |
| SMARCA4 SRX5212357 | Mel270 Others | 255 / 9743 (2.6%) | 8084 / 97430 (8.3%) | −112.7 | −110.5 | 0.32 |
| FOXA1 SRX11222441 | MCF-7 Breast | 125 / 9743 (1.3%) | 5779 / 97430 (5.9%) | −111.9 | −109.6 | 0.22 |
| CEBPA SRX2630241 | Hep G2 Liver | 217 / 9743 (2.2%) | 7425 / 97430 (7.6%) | −111.8 | −109.6 | 0.29 |
| FOXA2 SRX100448 | Hep G2 Liver | 194 / 9743 (2.0%) | 7029 / 97430 (7.2%) | −111.8 | −109.5 | 0.28 |
| ESR1 SRX10365536 | MCF-7 Breast | 80 / 9743 (0.8%) | 4875 / 97430 (5.0%) | −111.7 | −109.4 | 0.16 |
| KAT7 SRX101303 | RKO Digestive tract | 792 / 9743 (8.1%) | 3000 / 97430 (3.1%) | −111.7 | −109.4 | 2.64 |
| FOXA1 SRX1787653 | MCF-7 Breast | 139 / 9743 (1.4%) | 6037 / 97430 (6.2%) | −111.6 | −109.3 | 0.23 |
| NR2F2 SRX190293 | MCF-7 Breast | 186 / 9743 (1.9%) | 6880 / 97430 (7.1%) | −111.5 | −109.2 | 0.27 |
| BRD1 SRX286203 | RKO Digestive tract | 691 / 9743 (7.1%) | 2411 / 97430 (2.5%) | −110.7 | −108.5 | 2.87 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 557 / 9743 (5.7%) | 12514 / 97430 (12.8%) | −110.1 | −107.9 | 0.45 |
| JUNB SRX8488073 | SUM 229PE Breast | 351 / 9743 (3.6%) | 9499 / 97430 (9.7%) | −109.8 | −107.5 | 0.37 |
| FOXA1 SRX1161174 | MCF-7 Breast | 185 / 9743 (1.9%) | 6804 / 97430 (7.0%) | −109.6 | −107.4 | 0.27 |
| RAC1 SRX10365541 | MCF-7 Breast | 82 / 9743 (0.8%) | 4848 / 97430 (5.0%) | −109.3 | −107.1 | 0.17 |
| ESR1 SRX20282940 | MCF-7 Breast | 199 / 9743 (2.0%) | 7036 / 97430 (7.2%) | −109.2 | −107.0 | 0.28 |
| TEAD1 SRX3401272 | MCF-7 Breast | 128 / 9743 (1.3%) | 5756 / 97430 (5.9%) | −109.1 | −106.9 | 0.22 |
| ESR1 SRX20282973 | MCF-7 Breast | 223 / 9743 (2.3%) | 7436 / 97430 (7.6%) | −109.1 | −106.8 | 0.30 |
| JUN SRX17561461 | LPS141 Adipocyte | 266 / 9743 (2.7%) | 8138 / 97430 (8.4%) | −108.9 | −106.7 | 0.33 |
| TLE3 SRX4815192 | MCF-7 Breast | 157 / 9743 (1.6%) | 6284 / 97430 (6.4%) | −108.8 | −106.6 | 0.25 |
| ESR1 SRX371475 | BT-474 Breast | 75 / 9743 (0.8%) | 4675 / 97430 (4.8%) | −108.4 | −106.2 | 0.16 |
| ESR1 SRX20282955 | MCF-7 Breast | 195 / 9743 (2.0%) | 6924 / 97430 (7.1%) | −107.9 | −105.7 | 0.28 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 68 / 9743 (0.7%) | 4507 / 97430 (4.6%) | −107.8 | −105.6 | 0.15 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 1197 / 9743 (12.3%) | 5764 / 97430 (5.9%) | −107.6 | −105.4 | 2.08 |
| ARID1A SRX5089379 | MCF-7 Breast | 178 / 9743 (1.8%) | 6620 / 97430 (6.8%) | −107.6 | −105.3 | 0.27 |
| RAC1 SRX10365543 | MCF-7 Breast | 89 / 9743 (0.9%) | 4930 / 97430 (5.1%) | −107.0 | −104.8 | 0.18 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 171 / 9743 (1.8%) | 6476 / 97430 (6.6%) | −107.0 | −104.8 | 0.26 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 240 / 9743 (2.5%) | 7632 / 97430 (7.8%) | −106.4 | −104.2 | 0.31 |
| SMARCA4 SRX5212371 | Mel270 Others | 264 / 9743 (2.7%) | 8017 / 97430 (8.2%) | −106.3 | −104.0 | 0.33 |
| CDK9 SRX7366779 | MCF-7 Breast | 158 / 9743 (1.6%) | 75 / 97430 (0.1%) | −105.8 | −103.5 | 21.07 |
| AR SRX9469988 | LAPC-4 Prostate | 250 / 9743 (2.6%) | 7771 / 97430 (8.0%) | −105.7 | −103.5 | 0.32 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 571 / 9743 (5.9%) | 12534 / 97430 (12.9%) | −105.7 | −103.5 | 0.46 |
| JUN SRX6582171 | GM07492 Others | 372 / 9743 (3.8%) | 9671 / 97430 (9.9%) | −105.7 | −103.5 | 0.38 |
| ESR1 SRX2881002 | MCF-7 Breast | 172 / 9743 (1.8%) | 6452 / 97430 (6.6%) | −105.6 | −103.4 | 0.27 |
| FOS SRX4192879 | MCF 10A Breast | 212 / 9743 (2.2%) | 7141 / 97430 (7.3%) | −105.6 | −103.4 | 0.30 |
| ESR1 SRX4367192 | MCF-7 Breast | 403 / 9743 (4.1%) | 10127 / 97430 (10.4%) | −105.5 | −103.3 | 0.40 |
| VGLL1 SRX24602130 | BT-20 Breast | 189 / 9743 (1.9%) | 6741 / 97430 (6.9%) | −105.3 | −103.1 | 0.28 |
| FOXA1 SRX1161203 | T-47D Breast | 120 / 9743 (1.2%) | 5478 / 97430 (5.6%) | −104.9 | −102.7 | 0.22 |
| FOXA1 SRX11222437 | MCF-7 Breast | 127 / 9743 (1.3%) | 5607 / 97430 (5.8%) | −104.7 | −102.5 | 0.23 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 536 / 9743 (5.5%) | 1619 / 97430 (1.7%) | −104.7 | −102.5 | 3.31 |
| ESR1 SRX371474 | BT-474 Breast | 70 / 9743 (0.7%) | 4463 / 97430 (4.6%) | −104.5 | −102.4 | 0.16 |
| ESR1 SRX2881000 | MCF-7 Breast | 159 / 9743 (1.6%) | 6185 / 97430 (6.3%) | −104.3 | −102.2 | 0.26 |
| FOXA1 SRX1787652 | MCF-7 Breast | 104 / 9743 (1.1%) | 5151 / 97430 (5.3%) | −104.3 | −102.1 | 0.20 |
| FOXA1 SRX11222442 | MCF-7 Breast | 113 / 9743 (1.2%) | 5322 / 97430 (5.5%) | −104.1 | −102.0 | 0.21 |
| EP300 SRX2194266 | SUM 159PT Breast | 333 / 9743 (3.4%) | 9014 / 97430 (9.3%) | −103.9 | −101.7 | 0.37 |
| FOXA1 SRX3923514 | MCF-7 Breast | 191 / 9743 (2.0%) | 6718 / 97430 (6.9%) | −103.6 | −101.5 | 0.28 |
| AR SRX9109110 | MDA-MB-453 Breast | 372 / 9743 (3.8%) | 9594 / 97430 (9.8%) | −103.5 | −101.4 | 0.39 |
| ESR1 SRX5323873 | MCF-7 Breast | 235 / 9743 (2.4%) | 7449 / 97430 (7.6%) | −103.4 | −101.2 | 0.32 |
| ESR1 SRX20282946 | MCF-7 Breast | 100 / 9743 (1.0%) | 5043 / 97430 (5.2%) | −103.1 | −101.0 | 0.20 |
| FOXA1 SRX3931043 | MCF-7 Breast | 196 / 9743 (2.0%) | 6786 / 97430 (7.0%) | −103.0 | −100.9 | 0.29 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 142 / 9743 (1.5%) | 5835 / 97430 (6.0%) | −103.0 | −100.8 | 0.24 |
| GATAD2A SRX2636506 | Hep G2 Liver | 249 / 9743 (2.6%) | 7648 / 97430 (7.8%) | −102.5 | −100.3 | 0.33 |
| Epitope tags SRX5877914 | U2OS Bone | 1140 / 9743 (11.7%) | 19777 / 97430 (20.3%) | −102.4 | −100.2 | 0.58 |
| ESR1 SRX330070 | MCF-7 Breast | 83 / 9743 (0.9%) | 4674 / 97430 (4.8%) | −102.2 | −100.1 | 0.18 |
| Epitope tags SRX392690 | T3M-1 Cl-10 Others | 131 / 9743 (1.3%) | 35 / 97430 (0.0%) | −102.2 | −100.0 | 37.43 |
| WWTR1 SRX10119367 | MCF 10A Breast | 221 / 9743 (2.3%) | 7177 / 97430 (7.4%) | −102.1 | −99.9 | 0.31 |
| EP300 SRX176885 | MCF-7 Breast | 85 / 9743 (0.9%) | 4702 / 97430 (4.8%) | −101.8 | −99.7 | 0.18 |
| FOXA1 SRX100477 | Hep G2 Liver | 219 / 9743 (2.2%) | 7129 / 97430 (7.3%) | −101.7 | −99.5 | 0.31 |
| ATF1 SRX11470450 | Mesenchymal stem cells Others | 383 / 9743 (3.9%) | 9682 / 97430 (9.9%) | −101.5 | −99.4 | 0.40 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 166 / 9743 (1.7%) | 6219 / 97430 (6.4%) | −101.5 | −99.3 | 0.27 |
| EP300 SRX1012648 | MCF-7 Breast | 77 / 9743 (0.8%) | 4518 / 97430 (4.6%) | −101.2 | −99.0 | 0.17 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 346 / 9743 (3.6%) | 9114 / 97430 (9.4%) | −101.1 | −99.0 | 0.38 |
| STAT3 SRX2020842 | HCC70 Breast | 358 / 9743 (3.7%) | 9288 / 97430 (9.5%) | −100.9 | −98.8 | 0.39 |
| CEBPB SRX190345 | MCF-7 Breast | 140 / 9743 (1.4%) | 5728 / 97430 (5.9%) | −100.7 | −98.6 | 0.24 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 390 / 9743 (4.0%) | 9748 / 97430 (10.0%) | −100.5 | −98.4 | 0.40 |
| ESR1 SRX20282953 | MCF-7 Breast | 152 / 9743 (1.6%) | 5938 / 97430 (6.1%) | −100.4 | −98.3 | 0.26 |
| ESR1 SRX10365532 | MCF-7 Breast | 95 / 9743 (1.0%) | 4865 / 97430 (5.0%) | −100.4 | −98.3 | 0.20 |
| NR1H3 SRX1538760 | HT-29 Digestive tract | 178 / 9743 (1.8%) | 6393 / 97430 (6.6%) | −100.3 | −98.2 | 0.28 |
| PBX3 SRX190343 | SK-N-SH Neural | 414 / 9743 (4.2%) | 10093 / 97430 (10.4%) | −100.3 | −98.2 | 0.41 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 174 / 9743 (1.8%) | 6319 / 97430 (6.5%) | −100.2 | −98.1 | 0.28 |
| FOXA1 SRX3931054 | MCF-7 Breast | 183 / 9743 (1.9%) | 6470 / 97430 (6.6%) | −100.2 | −98.0 | 0.28 |
| SMARCA4 SRX5075175 | Neural progenitor cells Neural | 296 / 9743 (3.0%) | 8307 / 97430 (8.5%) | −100.0 | −97.9 | 0.36 |
| ESR1 SRX20282971 | MCF-7 Breast | 188 / 9743 (1.9%) | 6547 / 97430 (6.7%) | −99.8 | −97.7 | 0.29 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 211 / 9743 (2.2%) | 6931 / 97430 (7.1%) | −99.7 | −97.6 | 0.30 |
| ESR1 SRX20282959 | MCF-7 Breast | 65 / 9743 (0.7%) | 4216 / 97430 (4.3%) | −99.6 | −97.4 | 0.15 |
| DAXX SRX1021630 | PC-3 Prostate | 194 / 9743 (2.0%) | 6632 / 97430 (6.8%) | −99.3 | −97.2 | 0.29 |
| FOXA1 SRX1961157 | T-47D Breast | 210 / 9743 (2.2%) | 6889 / 97430 (7.1%) | −98.9 | −96.8 | 0.30 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 489 / 9743 (5.0%) | 1437 / 97430 (1.5%) | −98.8 | −96.7 | 3.40 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 194 / 9743 (2.0%) | 6614 / 97430 (6.8%) | −98.8 | −96.6 | 0.29 |
| ESR1 SRX10365558 | MCF-7 Breast | 126 / 9743 (1.3%) | 5410 / 97430 (5.6%) | −98.7 | −96.6 | 0.23 |
| CEBPB SRX11379527 | Liposarcoma, Myxoid Adipocyte | 353 / 9743 (3.6%) | 9130 / 97430 (9.4%) | −98.6 | −96.5 | 0.39 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 214 / 9743 (2.2%) | 6941 / 97430 (7.1%) | −98.5 | −96.4 | 0.31 |
| JUN SRX4192884 | MCF 10A Breast | 157 / 9743 (1.6%) | 5964 / 97430 (6.1%) | −98.5 | −96.4 | 0.26 |
| FOXA1 SRX1961158 | T-47D Breast | 189 / 9743 (1.9%) | 6520 / 97430 (6.7%) | −98.5 | −96.4 | 0.29 |
| ESR1 SRX330067 | MCF-7 Breast | 175 / 9743 (1.8%) | 6276 / 97430 (6.4%) | −98.4 | −96.3 | 0.28 |
| FOXA1 SRX3931055 | MCF-7 Breast | 164 / 9743 (1.7%) | 6078 / 97430 (6.2%) | −98.2 | −96.1 | 0.27 |
| AR SRX9109113 | MDA-MB-453 Breast | 388 / 9743 (4.0%) | 9633 / 97430 (9.9%) | −98.1 | −96.0 | 0.40 |
| SSRP1 SRX3436566 | HT-1080 Bone | 203 / 9743 (2.1%) | 209 / 97430 (0.2%) | −98.1 | −96.0 | 9.71 |
| ESR1 SRX3110725 | MCF-7 Breast | 175 / 9743 (1.8%) | 6262 / 97430 (6.4%) | −98.0 | −95.9 | 0.28 |
| TEAD3 SRX2636153 | Hep G2 Liver | 493 / 9743 (5.1%) | 11137 / 97430 (11.4%) | −98.0 | −95.9 | 0.44 |
| ESR1 SRX2943589 | MCF-7 Breast | 87 / 9743 (0.9%) | 4626 / 97430 (4.7%) | −97.8 | −95.7 | 0.19 |
| EP300 SRX2671813 | Fibroblasts Others | 155 / 9743 (1.6%) | 5902 / 97430 (6.1%) | −97.6 | −95.5 | 0.26 |
| FOXA1 SRX5323829 | T-47D Breast | 96 / 9743 (1.0%) | 4797 / 97430 (4.9%) | −97.5 | −95.4 | 0.20 |
| BRPF3 SRX796084 | RKO Digestive tract | 846 / 9743 (8.7%) | 3591 / 97430 (3.7%) | −97.4 | −95.3 | 2.36 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 202 / 9743 (2.1%) | 6703 / 97430 (6.9%) | −97.4 | −95.3 | 0.30 |
| JUNB SRX10119386 | MCF 10A Breast | 172 / 9743 (1.8%) | 6187 / 97430 (6.4%) | −97.2 | −95.2 | 0.28 |
| ESR1 SRX5323872 | MCF-7 Breast | 196 / 9743 (2.0%) | 6596 / 97430 (6.8%) | −97.1 | −95.0 | 0.30 |
| FOXA1 SRX15430999 | T-47D Breast | 216 / 9743 (2.2%) | 6929 / 97430 (7.1%) | −97.1 | −95.0 | 0.31 |
| ZEB1 SRX13298925 | MCF-7 Breast | 108 / 9743 (1.1%) | 5018 / 97430 (5.2%) | −97.0 | −95.0 | 0.22 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 181 / 9743 (1.9%) | 6333 / 97430 (6.5%) | −96.9 | −94.8 | 0.29 |
| ESR1 SRX1012632 | MCF-7 Breast | 87 / 9743 (0.9%) | 4598 / 97430 (4.7%) | −96.8 | −94.8 | 0.19 |
| PRRX1 SRX15235713 | Hs 578T Breast | 241 / 9743 (2.5%) | 7324 / 97430 (7.5%) | −96.7 | −94.6 | 0.33 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 179 / 9743 (1.8%) | 6293 / 97430 (6.5%) | −96.7 | −94.6 | 0.28 |
| BRPF3 SRX796085 | RKO Digestive tract | 604 / 9743 (6.2%) | 2104 / 97430 (2.2%) | −96.6 | −94.5 | 2.87 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 397 / 9743 (4.1%) | 9703 / 97430 (10.0%) | −96.5 | −94.5 | 0.41 |
| FOXA1 SRX5323843 | MCF-7 Breast | 91 / 9743 (0.9%) | 4672 / 97430 (4.8%) | −96.5 | −94.4 | 0.19 |
| ESR1 SRX8537722 | MCF-7 Breast | 184 / 9743 (1.9%) | 6373 / 97430 (6.5%) | −96.5 | −94.4 | 0.29 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 187 / 9743 (1.9%) | 6421 / 97430 (6.6%) | −96.4 | −94.3 | 0.29 |
| ESR1 SRX5323878 | MCF-7 Breast | 197 / 9743 (2.0%) | 6576 / 97430 (6.7%) | −96.1 | −94.0 | 0.30 |
| NR1H3 SRX1538763 | HT-29 Digestive tract | 184 / 9743 (1.9%) | 6357 / 97430 (6.5%) | −96.1 | −94.0 | 0.29 |
| SOX13 SRX2636248 | Hep G2 Liver | 278 / 9743 (2.9%) | 7888 / 97430 (8.1%) | −96.0 | −93.9 | 0.35 |
| PROX1 SRX3230397 | Hep G2 Liver | 137 / 9743 (1.4%) | 5526 / 97430 (5.7%) | −96.0 | −93.9 | 0.25 |
| AR SRX1067066 | LHSAR Prostate | 435 / 9743 (4.5%) | 10233 / 97430 (10.5%) | −95.9 | −93.9 | 0.43 |
| ESR1 SRX20282938 | MCF-7 Breast | 157 / 9743 (1.6%) | 5881 / 97430 (6.0%) | −95.9 | −93.8 | 0.27 |
| GATA3 SRX5457550 | MCF-7 Breast | 232 / 9743 (2.4%) | 7147 / 97430 (7.3%) | −95.8 | −93.8 | 0.32 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 166 / 9743 (1.7%) | 6037 / 97430 (6.2%) | −95.7 | −93.7 | 0.27 |
| ESR1 SRX5323871 | MCF-7 Breast | 218 / 9743 (2.2%) | 6912 / 97430 (7.1%) | −95.6 | −93.6 | 0.32 |
| FOXA1 SRX028634 | MCF-7 Breast | 91 / 9743 (0.9%) | 4643 / 97430 (4.8%) | −95.6 | −93.5 | 0.20 |
| EP300 SRX150579 | HeLa Uterus | 120 / 9743 (1.2%) | 5201 / 97430 (5.3%) | −95.5 | −93.5 | 0.23 |
| ARID5B SRX10475138 | Hep G2 Liver | 343 / 9743 (3.5%) | 8861 / 97430 (9.1%) | −95.4 | −93.4 | 0.39 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 189 / 9743 (1.9%) | 6414 / 97430 (6.6%) | −95.2 | −93.1 | 0.29 |
| TFAP2C SRX018833 | MCF-7 Breast | 177 / 9743 (1.8%) | 6207 / 97430 (6.4%) | −95.2 | −93.1 | 0.29 |
| CEBPB SRX2194250 | SUM 159PT Breast | 244 / 9743 (2.5%) | 7319 / 97430 (7.5%) | −95.2 | −93.1 | 0.33 |
| ESR1 SRX3123829 | MCF-7 Breast | 105 / 9743 (1.1%) | 4902 / 97430 (5.0%) | −95.0 | −93.0 | 0.21 |
| ESR1 SRX1012629 | MCF-7 Breast | 120 / 9743 (1.2%) | 5185 / 97430 (5.3%) | −94.9 | −92.9 | 0.23 |
| ARID1A SRX5089385 | MCF-7 Breast | 144 / 9743 (1.5%) | 5619 / 97430 (5.8%) | −94.8 | −92.7 | 0.26 |
| Epitope tags SRX11470449 | Mesenchymal stem cells Others | 302 / 9743 (3.1%) | 8215 / 97430 (8.4%) | −94.8 | −92.7 | 0.37 |
| ESR1 SRX4451213 | MCF-7 Breast | 206 / 9743 (2.1%) | 6686 / 97430 (6.9%) | −94.7 | −92.7 | 0.31 |
| FOXA1 SRX1787655 | MCF-7 Breast | 90 / 9743 (0.9%) | 4588 / 97430 (4.7%) | −94.4 | −92.4 | 0.20 |
| TAZ SRX14181208 | MSK-PCa3 Prostate | 209 / 9743 (2.1%) | 6716 / 97430 (6.9%) | −94.3 | −92.2 | 0.31 |
| STAT3 SRX150479 | MCF 10A Breast | 184 / 9743 (1.9%) | 6297 / 97430 (6.5%) | −94.2 | −92.2 | 0.29 |
| EP300 SRX1012644 | MCF-7 Breast | 81 / 9743 (0.8%) | 4402 / 97430 (4.5%) | −94.1 | −92.1 | 0.18 |
| NCOA1 SRX036638 | U2OS Bone | 128 / 9743 (1.3%) | 44 / 97430 (0.0%) | −94.1 | −92.1 | 29.09 |
| TFAP2C SRX128099 | MCF-7 Breast | 179 / 9743 (1.8%) | 6207 / 97430 (6.4%) | −94.1 | −92.0 | 0.29 |
| NR3C1 SRX2609664 | HASM2 Lung | 285 / 9743 (2.9%) | 7919 / 97430 (8.1%) | −93.9 | −91.8 | 0.36 |
| ESR1 SRX1012633 | MCF-7 Breast | 95 / 9743 (1.0%) | 4669 / 97430 (4.8%) | −93.7 | −91.7 | 0.20 |
| FOXA1 SRX1787651 | MCF-7 Breast | 108 / 9743 (1.1%) | 4920 / 97430 (5.0%) | −93.7 | −91.6 | 0.22 |
| LEO1 SRX1873456 | SEM Blood | 830 / 9743 (8.5%) | 3560 / 97430 (3.7%) | −93.6 | −91.5 | 2.33 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 304 / 9743 (3.1%) | 8200 / 97430 (8.4%) | −93.5 | −91.4 | 0.37 |
| JUNB SRX8488074 | SUM 229PE Breast | 272 / 9743 (2.8%) | 7699 / 97430 (7.9%) | −93.3 | −91.3 | 0.35 |
| FOXA1 SRX5323830 | T-47D Breast | 109 / 9743 (1.1%) | 4927 / 97430 (5.1%) | −93.3 | −91.2 | 0.22 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 291 / 9743 (3.0%) | 7989 / 97430 (8.2%) | −93.2 | −91.2 | 0.36 |
| CDK9 SRX7366780 | MCF-7 Breast | 138 / 9743 (1.4%) | 64 / 97430 (0.1%) | −93.1 | −91.1 | 21.56 |
| FOXA1 SRX6878603 | LNCAP Prostate | 227 / 9743 (2.3%) | 6973 / 97430 (7.2%) | −93.1 | −91.1 | 0.33 |
| ARID1A SRX5089391 | MCF-7 Breast | 104 / 9743 (1.1%) | 4826 / 97430 (5.0%) | −93.1 | −91.1 | 0.22 |
| NUP98 SRX20440536 | Keratinocytes Epidermis | 303 / 9743 (3.1%) | 598 / 97430 (0.6%) | −93.1 | −91.1 | 5.07 |
| PGR SRX1012655 | MCF-7 Breast | 122 / 9743 (1.3%) | 5167 / 97430 (5.3%) | −93.1 | −91.1 | 0.24 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 91 / 9743 (0.9%) | 4570 / 97430 (4.7%) | −93.1 | −91.1 | 0.20 |
| RELA SRX5938177 | FaDu Others | 184 / 9743 (1.9%) | 6257 / 97430 (6.4%) | −93.0 | −91.0 | 0.29 |
| CIC SRX13262055 | Astrocytes Neural | 1678 / 9743 (17.2%) | 9765 / 97430 (10.0%) | −93.0 | −91.0 | 1.72 |
| FOXA1 SRX3923518 | MCF-7 Breast | 137 / 9743 (1.4%) | 5438 / 97430 (5.6%) | −93.0 | −91.0 | 0.25 |
| JUNB SRX4192882 | MCF 10A Breast | 156 / 9743 (1.6%) | 5764 / 97430 (5.9%) | −92.7 | −90.7 | 0.27 |
| FOXL2 SRX6957431 | KGN Gonad | 479 / 9743 (4.9%) | 10733 / 97430 (11.0%) | −92.7 | −90.6 | 0.45 |
| ESR1 SRX1531796 | MCF-7 Breast | 100 / 9743 (1.0%) | 4727 / 97430 (4.9%) | −92.4 | −90.4 | 0.21 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 188 / 9743 (1.9%) | 6305 / 97430 (6.5%) | −92.4 | −90.4 | 0.30 |
| STAT3 SRX150536 | MCF 10A Breast | 227 / 9743 (2.3%) | 6946 / 97430 (7.1%) | −92.3 | −90.3 | 0.33 |
| STAT3 SRX150630 | MCF 10A Breast | 187 / 9743 (1.9%) | 6282 / 97430 (6.4%) | −92.2 | −90.2 | 0.30 |
| FOXA1 SRX3923517 | MCF-7 Breast | 142 / 9743 (1.5%) | 5505 / 97430 (5.7%) | −92.2 | −90.2 | 0.26 |
| SS18 SRX10640842 | SK-MEL-147 Epidermis | 265 / 9743 (2.7%) | 7551 / 97430 (7.8%) | −92.2 | −90.2 | 0.35 |
| STAT3 SRX5323860 | MCF-7 Breast | 261 / 9743 (2.7%) | 7489 / 97430 (7.7%) | −92.2 | −90.2 | 0.35 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 450 / 9743 (4.6%) | 1308 / 97430 (1.3%) | −92.1 | −90.1 | 3.44 |
| VGLL1 SRX18013277 | FULVR Breast | 73 / 9743 (0.7%) | 4177 / 97430 (4.3%) | −92.0 | −90.0 | 0.17 |
| AR SRX1067067 | LHSAR Prostate | 354 / 9743 (3.6%) | 8899 / 97430 (9.1%) | −92.0 | −90.0 | 0.40 |
| Epitope tags SRX5877913 | U2OS Bone | 1162 / 9743 (11.9%) | 19538 / 97430 (20.1%) | −91.8 | −89.8 | 0.59 |
| FOXA2 SRX10475773 | Hep G2 Liver | 255 / 9743 (2.6%) | 7378 / 97430 (7.6%) | −91.8 | −89.8 | 0.35 |
| GATA3 SRX6712581 | MCF-7 Breast | 168 / 9743 (1.7%) | 5943 / 97430 (6.1%) | −91.7 | −89.8 | 0.28 |
| ESR1 SRX10365533 | MCF-7 Breast | 91 / 9743 (0.9%) | 4530 / 97430 (4.6%) | −91.7 | −89.7 | 0.20 |
| ESR1 SRX2912055 | MCF-7 Breast | 69 / 9743 (0.7%) | 4076 / 97430 (4.2%) | −91.5 | −89.5 | 0.17 |
| ESR1 SRX2513517 | MCF-7 Breast | 135 / 9743 (1.4%) | 5354 / 97430 (5.5%) | −91.5 | −89.5 | 0.25 |
| HMG20A SRX2630163 | Hep G2 Liver | 109 / 9743 (1.1%) | 4870 / 97430 (5.0%) | −91.4 | −89.5 | 0.22 |
| SMARCC1 SRX11379506 | Liposarcoma, Myxoid Adipocyte | 365 / 9743 (3.7%) | 9042 / 97430 (9.3%) | −91.4 | −89.5 | 0.40 |
| WWTR1 SRX10119378 | MCF 10A Breast | 219 / 9743 (2.2%) | 6787 / 97430 (7.0%) | −91.4 | −89.4 | 0.32 |
| FOXA1 SRX1447317 | MCF-7 Breast | 129 / 9743 (1.3%) | 5238 / 97430 (5.4%) | −91.3 | −89.3 | 0.25 |
| CEBPA SRX4705113 | MOLM-13 Blood | 494 / 9743 (5.1%) | 10879 / 97430 (11.2%) | −91.1 | −89.2 | 0.45 |
| FOXA1 SRX028635 | MCF-7 Breast | 96 / 9743 (1.0%) | 4614 / 97430 (4.7%) | −91.1 | −89.1 | 0.21 |
| NKX2-1 SRX2164786 | A549 Lung | 345 / 9743 (3.5%) | 8730 / 97430 (9.0%) | −91.0 | −89.1 | 0.40 |
| FOXA1 SRX9550865 | Prostate cancer Prostate | 408 / 9743 (4.2%) | 9654 / 97430 (9.9%) | −91.0 | −89.0 | 0.42 |
| ESR1 SRX1469949 | MCF-7 Breast | 112 / 9743 (1.1%) | 4905 / 97430 (5.0%) | −90.7 | −88.8 | 0.23 |
| FOXA1 SRX11222438 | MCF-7 Breast | 104 / 9743 (1.1%) | 4742 / 97430 (4.9%) | −90.4 | −88.4 | 0.22 |
| FOXA1 SRX1161205 | T-47D Breast | 100 / 9743 (1.0%) | 4664 / 97430 (4.8%) | −90.3 | −88.3 | 0.21 |
| SMARCC1 SRX11379511 | Liposarcoma, Myxoid Adipocyte | 281 / 9743 (2.9%) | 7732 / 97430 (7.9%) | −90.2 | −88.3 | 0.36 |
| TP53 SRX2585782 | MDA-MB-231 Breast | 393 / 9743 (4.0%) | 9406 / 97430 (9.7%) | −90.2 | −88.2 | 0.42 |
| RNF2 SRX18954702 | FaDu Others | 481 / 9743 (4.9%) | 10659 / 97430 (10.9%) | −90.2 | −88.2 | 0.45 |
| Epitope tags SRX8080558 | Mammary gland adenocarcinoma Breast | 65 / 9743 (0.7%) | 3953 / 97430 (4.1%) | −90.0 | −88.1 | 0.16 |
| BRPF3 SRX796086 | RKO Digestive tract | 788 / 9743 (8.1%) | 3354 / 97430 (3.4%) | −90.0 | −88.1 | 2.35 |
| SMARCA4 SRX8566546 | 786-O Kidney | 747 / 9743 (7.7%) | 14216 / 97430 (14.6%) | −89.5 | −87.6 | 0.53 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 426 / 9743 (4.4%) | 1212 / 97430 (1.2%) | −89.5 | −87.6 | 3.51 |
| ESR1 SRX792933 | LY2 Breast | 171 / 9743 (1.8%) | 5923 / 97430 (6.1%) | −89.5 | −87.5 | 0.29 |
| Epitope tags SRX20741925 | Hep G2 Liver | 367 / 9743 (3.8%) | 8998 / 97430 (9.2%) | −89.4 | −87.5 | 0.41 |
| YAP1 SRX10119364 | MCF 10A Breast | 169 / 9743 (1.7%) | 5883 / 97430 (6.0%) | −89.4 | −87.4 | 0.29 |
| ARID5B SRX10475139 | Hep G2 Liver | 229 / 9743 (2.4%) | 6872 / 97430 (7.1%) | −89.2 | −87.3 | 0.33 |
| ARID1A SRX5089382 | MCF-7 Breast | 144 / 9743 (1.5%) | 5444 / 97430 (5.6%) | −89.2 | −87.2 | 0.26 |
| JUN SRX6582172 | Fibroblasts Others | 278 / 9743 (2.9%) | 7646 / 97430 (7.8%) | −89.1 | −87.2 | 0.36 |
| SMARCA4 SRX15419260 | 786-O Kidney | 749 / 9743 (7.7%) | 14214 / 97430 (14.6%) | −89.0 | −87.0 | 0.53 |
| FOXA1 SRX3923516 | MCF-7 Breast | 149 / 9743 (1.5%) | 5522 / 97430 (5.7%) | −88.9 | −87.0 | 0.27 |
| ZEB1 SRX13298924 | MCF-7 Breast | 88 / 9743 (0.9%) | 4388 / 97430 (4.5%) | −88.9 | −87.0 | 0.20 |
| MethylCap SRX014766 | NB-4 Blood | 911 / 9743 (9.4%) | 4201 / 97430 (4.3%) | −88.8 | −86.8 | 2.17 |
| JUNB SRX8488089 | SUM 229PE Breast | 211 / 9743 (2.2%) | 6565 / 97430 (6.7%) | −88.8 | −86.8 | 0.32 |
| ESR1 SRX2513520 | MCF-7 Breast | 125 / 9743 (1.3%) | 5086 / 97430 (5.2%) | −88.7 | −86.8 | 0.25 |
| ESR1 SRX1012628 | MCF-7 Breast | 99 / 9743 (1.0%) | 4596 / 97430 (4.7%) | −88.7 | −86.7 | 0.22 |
| FOXA1 SRX1161207 | T-47D Breast | 73 / 9743 (0.7%) | 4077 / 97430 (4.2%) | −88.6 | −86.6 | 0.18 |
| ESR1 SRX1012630 | MCF-7 Breast | 70 / 9743 (0.7%) | 4013 / 97430 (4.1%) | −88.5 | −86.6 | 0.17 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 163 / 9743 (1.7%) | 5754 / 97430 (5.9%) | −88.5 | −86.5 | 0.28 |
| FOSL1 SRX190212 | HCT 116 Digestive tract | 241 / 9743 (2.5%) | 7041 / 97430 (7.2%) | −88.5 | −86.5 | 0.34 |
| FOXA1 SRX15430988 | MDA-MB-453 Breast | 213 / 9743 (2.2%) | 6589 / 97430 (6.8%) | −88.4 | −86.5 | 0.32 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 168 / 9743 (1.7%) | 5835 / 97430 (6.0%) | −88.4 | −86.5 | 0.29 |
| CDK9 SRX7366782 | MCF-7 Breast | 129 / 9743 (1.3%) | 57 / 97430 (0.1%) | −88.4 | −86.5 | 22.63 |
| ESR1 SRX330069 | MCF-7 Breast | 125 / 9743 (1.3%) | 5078 / 97430 (5.2%) | −88.4 | −86.5 | 0.25 |
| SS18 SRX10881848 | G-401 Kidney | 282 / 9743 (2.9%) | 7680 / 97430 (7.9%) | −88.4 | −86.4 | 0.37 |
| ESR1 SRX330068 | MCF-7 Breast | 92 / 9743 (0.9%) | 4450 / 97430 (4.6%) | −88.3 | −86.4 | 0.21 |
| ESR1 SRX5323877 | MCF-7 Breast | 162 / 9743 (1.7%) | 5724 / 97430 (5.9%) | −88.1 | −86.1 | 0.28 |
| ING5 SRX286202 | RKO Digestive tract | 727 / 9743 (7.5%) | 2997 / 97430 (3.1%) | −88.0 | −86.1 | 2.43 |
| FOXA1 SRX9604647 | LNCAP Prostate | 329 / 9743 (3.4%) | 8372 / 97430 (8.6%) | −87.8 | −85.8 | 0.39 |
| ESR1 SRX5534831 | MCF-7 Breast | 161 / 9743 (1.7%) | 5691 / 97430 (5.8%) | −87.7 | −85.8 | 0.28 |
| EP300 SRX2194265 | SUM 159PT Breast | 336 / 9743 (3.4%) | 8470 / 97430 (8.7%) | −87.6 | −85.7 | 0.40 |
| ARID1A SRX5089388 | MCF-7 Breast | 103 / 9743 (1.1%) | 4637 / 97430 (4.8%) | −87.4 | −85.5 | 0.22 |
| ZNF219 SRX3230413 | Hep G2 Liver | 371 / 9743 (3.8%) | 8979 / 97430 (9.2%) | −87.4 | −85.4 | 0.41 |
| FOXA1 SRX3931033 | MCF-7 Breast | 136 / 9743 (1.4%) | 5240 / 97430 (5.4%) | −87.3 | −85.4 | 0.26 |
| FOXA1 SRX190181 | A549 Lung | 147 / 9743 (1.5%) | 5438 / 97430 (5.6%) | −87.3 | −85.3 | 0.27 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 147 / 9743 (1.5%) | 5438 / 97430 (5.6%) | −87.3 | −85.3 | 0.27 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 195 / 9743 (2.0%) | 6248 / 97430 (6.4%) | −87.1 | −85.2 | 0.31 |
| MITF SRX7368255 | Hermes 3C Epidermis | 619 / 9743 (6.4%) | 12421 / 97430 (12.7%) | −87.1 | −85.2 | 0.50 |
| EP300 SRX1012643 | MCF-7 Breast | 68 / 9743 (0.7%) | 3929 / 97430 (4.0%) | −87.1 | −85.1 | 0.17 |
| JUN SRX883584 | MDA-MB-231 Breast | 337 / 9743 (3.5%) | 8462 / 97430 (8.7%) | −87.0 | −85.1 | 0.40 |
| FOXA1 SRX219284 | LNCAP Prostate | 292 / 9743 (3.0%) | 7776 / 97430 (8.0%) | −86.9 | −85.0 | 0.38 |
| EP300 SRX176883 | MCF-7 Breast | 91 / 9743 (0.9%) | 4390 / 97430 (4.5%) | −86.9 | −85.0 | 0.21 |
| ESR1 SRX8537723 | MCF-7 Breast | 169 / 9743 (1.7%) | 5802 / 97430 (6.0%) | −86.8 | −84.9 | 0.29 |
| KDM1A SRX3321939 | Hep G2 Liver | 212 / 9743 (2.2%) | 6515 / 97430 (6.7%) | −86.8 | −84.9 | 0.33 |
| Epitope tags SRX11470534 | Mesenchymal stem cells Others | 396 / 9743 (4.1%) | 9306 / 97430 (9.6%) | −86.5 | −84.6 | 0.43 |
| SOX5 SRX2636544 | Hep G2 Liver | 212 / 9743 (2.2%) | 6506 / 97430 (6.7%) | −86.5 | −84.6 | 0.33 |
| ESR1 SRX2513521 | MCF-7 Breast | 93 / 9743 (1.0%) | 4416 / 97430 (4.5%) | −86.5 | −84.6 | 0.21 |
| KDM1A SRX10637290 | MDA-MB-231 Breast | 274 / 9743 (2.8%) | 7486 / 97430 (7.7%) | −86.5 | −84.6 | 0.37 |
| ESR1 SRX4451212 | MCF-7 Breast | 208 / 9743 (2.1%) | 6437 / 97430 (6.6%) | −86.4 | −84.5 | 0.32 |
| FOXA1 SRX5203303 | MCF-7 Breast | 64 / 9743 (0.7%) | 3826 / 97430 (3.9%) | −86.4 | −84.5 | 0.17 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 139 / 9743 (1.4%) | 5267 / 97430 (5.4%) | −86.4 | −84.5 | 0.26 |
| SS18 SRX10640843 | SK-MEL-147 Epidermis | 342 / 9743 (3.5%) | 8511 / 97430 (8.7%) | −86.4 | −84.4 | 0.40 |
| ESR1 SRX5323874 | MCF-7 Breast | 123 / 9743 (1.3%) | 4976 / 97430 (5.1%) | −86.3 | −84.4 | 0.25 |
| NANOG SRX10448024 | hESC H1 Pluripotent stem cell | 769 / 9743 (7.9%) | 14355 / 97430 (14.7%) | −86.3 | −84.4 | 0.54 |
| SMARCC1 SRX3927288 | EOL-1 Blood | 543 / 9743 (5.6%) | 11357 / 97430 (11.7%) | −86.2 | −84.3 | 0.48 |
| NFIL3 SRX2630334 | Hep G2 Liver | 172 / 9743 (1.8%) | 5831 / 97430 (6.0%) | −86.2 | −84.2 | 0.29 |
| ESR1 SRX1469951 | MCF-7 Breast | 106 / 9743 (1.1%) | 4652 / 97430 (4.8%) | −86.1 | −84.2 | 0.23 |
| FOXA1 SRX9550895 | Prostate cancer Prostate | 211 / 9743 (2.2%) | 6473 / 97430 (6.6%) | −86.0 | −84.1 | 0.33 |
| ZEB1 SRX13298923 | MCF-7 Breast | 77 / 9743 (0.8%) | 4081 / 97430 (4.2%) | −85.8 | −83.9 | 0.19 |
| KMT2C SRX1787675 | MCF-7 Breast | 188 / 9743 (1.9%) | 6084 / 97430 (6.2%) | −85.7 | −83.8 | 0.31 |
| FOXA1 SRX1787654 | MCF-7 Breast | 70 / 9743 (0.7%) | 3934 / 97430 (4.0%) | −85.7 | −83.8 | 0.18 |
| FOS SRX3322636 | MCF-7 Breast | 132 / 9743 (1.4%) | 5115 / 97430 (5.2%) | −85.6 | −83.7 | 0.26 |
| FOXA1 SRX3931032 | MCF-7 Breast | 123 / 9743 (1.3%) | 4954 / 97430 (5.1%) | −85.6 | −83.7 | 0.25 |
| GATAD2A SRX2636507 | Hep G2 Liver | 237 / 9743 (2.4%) | 6873 / 97430 (7.1%) | −85.5 | −83.6 | 0.34 |
| FOXA1 SRX3923519 | MCF-7 Breast | 129 / 9743 (1.3%) | 5059 / 97430 (5.2%) | −85.5 | −83.6 | 0.25 |
| FOXA2 SRX2368889 | Ker-CT Epidermis | 177 / 9743 (1.8%) | 5892 / 97430 (6.0%) | −85.4 | −83.5 | 0.30 |
| FOXA2 SRX2368888 | Ker-CT Epidermis | 203 / 9743 (2.1%) | 6323 / 97430 (6.5%) | −85.4 | −83.5 | 0.32 |
| MAU2 SRX15710550 | Fibroblasts Others | 356 / 9743 (3.7%) | 8679 / 97430 (8.9%) | −85.4 | −83.5 | 0.41 |
| NR3C1 SRX17639412 | A549 Lung | 242 / 9743 (2.5%) | 6946 / 97430 (7.1%) | −85.3 | −83.5 | 0.35 |
| CEBPB SRX2194249 | SUM 159PT Breast | 210 / 9743 (2.2%) | 6433 / 97430 (6.6%) | −85.3 | −83.4 | 0.33 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 221 / 9743 (2.3%) | 6614 / 97430 (6.8%) | −85.3 | −83.4 | 0.33 |
| FOXA1 SRX5323845 | MCF-7 Breast | 73 / 9743 (0.7%) | 3980 / 97430 (4.1%) | −85.1 | −83.2 | 0.18 |
| SP1 SRX190269 | A549 Lung | 313 / 9743 (3.2%) | 8028 / 97430 (8.2%) | −85.1 | −83.2 | 0.39 |
| NR3C1 SRX8520802 | HCC1187 Breast | 154 / 9743 (1.6%) | 5482 / 97430 (5.6%) | −85.0 | −83.1 | 0.28 |
| SP1 SRX190358 | HCT 116 Digestive tract | 333 / 9743 (3.4%) | 8325 / 97430 (8.5%) | −84.9 | −83.0 | 0.40 |
| EP300 SRX100544 | Hep G2 Liver | 163 / 9743 (1.7%) | 5629 / 97430 (5.8%) | −84.6 | −82.7 | 0.29 |
| EP300 SRX100540 | SK-N-SH Neural | 317 / 9743 (3.3%) | 8067 / 97430 (8.3%) | −84.5 | −82.6 | 0.39 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 137 / 9743 (1.4%) | 5169 / 97430 (5.3%) | −84.4 | −82.6 | 0.27 |
| Epitope tags SRX5877911 | U2OS Bone | 1098 / 9743 (11.3%) | 18386 / 97430 (18.9%) | −84.3 | −82.4 | 0.60 |
| MethylCap SRX014767 | NB-4 Blood | 976 / 9743 (10.0%) | 4759 / 97430 (4.9%) | −84.1 | −82.2 | 2.05 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 396 / 9743 (4.1%) | 9209 / 97430 (9.5%) | −84.1 | −82.2 | 0.43 |
| EP300 SRX22550927 | CDS1 Bone | 335 / 9743 (3.4%) | 8320 / 97430 (8.5%) | −84.0 | −82.2 | 0.40 |
| FOXA1 SRX9550928 | Prostate cancer Prostate | 279 / 9743 (2.9%) | 7474 / 97430 (7.7%) | −84.0 | −82.1 | 0.37 |
| GATA2 SRX3503584 | Endometrial stromal cells Uterus | 244 / 9743 (2.5%) | 6933 / 97430 (7.1%) | −84.0 | −82.1 | 0.35 |
| ESR1 SRX1012631 | MCF-7 Breast | 91 / 9743 (0.9%) | 4300 / 97430 (4.4%) | −83.8 | −81.9 | 0.21 |
| CBX3 SRX6712570 | MCF-7 Breast | 173 / 9743 (1.8%) | 5766 / 97430 (5.9%) | −83.7 | −81.8 | 0.30 |
| FOXA1 SRX6878604 | LNCAP Prostate | 175 / 9743 (1.8%) | 5801 / 97430 (6.0%) | −83.6 | −81.8 | 0.30 |
| NR3C1 SRX2609662 | HASM2 Lung | 262 / 9743 (2.7%) | 7199 / 97430 (7.4%) | −83.6 | −81.8 | 0.36 |
| ESR1 SRX20282966 | MCF-7 Breast | 70 / 9743 (0.7%) | 3874 / 97430 (4.0%) | −83.6 | −81.8 | 0.18 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 388 / 9743 (4.0%) | 9073 / 97430 (9.3%) | −83.5 | −81.6 | 0.43 |
| FOSL2 SRX190204 | A549 Lung | 211 / 9743 (2.2%) | 6384 / 97430 (6.6%) | −83.4 | −81.5 | 0.33 |
| Epitope tags SRX20741907 | Hep G2 Liver | 294 / 9743 (3.0%) | 7682 / 97430 (7.9%) | −83.4 | −81.5 | 0.38 |
| FOXA1 SRX9604645 | LNCAP Prostate | 316 / 9743 (3.2%) | 8008 / 97430 (8.2%) | −83.3 | −81.5 | 0.39 |
| FOSL2 SRX190296 | SK-N-SH Neural | 294 / 9743 (3.0%) | 7674 / 97430 (7.9%) | −83.3 | −81.4 | 0.38 |
| JUN SRX6582163 | BJ-5ta Epidermis | 275 / 9743 (2.8%) | 7385 / 97430 (7.6%) | −83.2 | −81.3 | 0.37 |
| Epitope tags SRX10549778 | K-562 Blood | 616 / 9743 (6.3%) | 2384 / 97430 (2.4%) | −83.1 | −81.3 | 2.58 |
| AHR SRX20282969 | MCF-7 Breast | 97 / 9743 (1.0%) | 4391 / 97430 (4.5%) | −83.1 | −81.2 | 0.22 |
| VGLL1 SRX18013279 | FULVR Breast | 99 / 9743 (1.0%) | 4429 / 97430 (4.5%) | −83.1 | −81.2 | 0.22 |
| FOXA1 SRX2642368 | VCaP Prostate | 270 / 9743 (2.8%) | 7303 / 97430 (7.5%) | −83.0 | −81.1 | 0.37 |
| Epitope tags SRX8080559 | Mammary gland adenocarcinoma Breast | 83 / 9743 (0.9%) | 4119 / 97430 (4.2%) | −82.9 | −81.1 | 0.20 |
| FOXA1 SRX6860635 | T-47D Breast | 165 / 9743 (1.7%) | 5604 / 97430 (5.8%) | −82.8 | −81.0 | 0.29 |
| SOX6 SRX10475370 | Hep G2 Liver | 394 / 9743 (4.0%) | 9132 / 97430 (9.4%) | −82.8 | −80.9 | 0.43 |
| NKX2-1 SRX366169 | NCI-H441 Lung | 263 / 9743 (2.7%) | 7181 / 97430 (7.4%) | −82.7 | −80.9 | 0.37 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 744 / 9743 (7.6%) | 3210 / 97430 (3.3%) | −82.6 | −80.8 | 2.32 |
| ESR1 SRX4451214 | MCF-7 Breast | 195 / 9743 (2.0%) | 6092 / 97430 (6.3%) | −82.5 | −80.7 | 0.32 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 144 / 9743 (1.5%) | 5231 / 97430 (5.4%) | −82.5 | −80.6 | 0.28 |
| CDK9 SRX7366784 | MCF-7 Breast | 122 / 9743 (1.3%) | 57 / 97430 (0.1%) | −82.2 | −80.4 | 21.40 |
| FOXA2 SRX3322259 | Hep G2 Liver | 138 / 9743 (1.4%) | 5117 / 97430 (5.3%) | −82.2 | −80.3 | 0.27 |
| FOXA1 SRX5323846 | MCF-7 Breast | 79 / 9743 (0.8%) | 4015 / 97430 (4.1%) | −82.2 | −80.3 | 0.20 |
| FOXA1 SRX9550898 | Prostate cancer Prostate | 149 / 9743 (1.5%) | 5308 / 97430 (5.4%) | −82.1 | −80.3 | 0.28 |
| MEIS1 SRX10269610 | MOLM-13 Blood | 658 / 9743 (6.8%) | 12717 / 97430 (13.1%) | −82.1 | −80.3 | 0.52 |
| Epitope tags SRX11470445 | Mesenchymal stem cells Others | 282 / 9743 (2.9%) | 7452 / 97430 (7.6%) | −82.1 | −80.2 | 0.38 |
| JUND SRX190357 | SK-N-SH Neural | 282 / 9743 (2.9%) | 7452 / 97430 (7.6%) | −82.1 | −80.2 | 0.38 |
| RNF2 SRX18954704 | FaDu Others | 532 / 9743 (5.5%) | 11028 / 97430 (11.3%) | −82.0 | −80.2 | 0.48 |
| ESR1 SRX2881001 | MCF-7 Breast | 119 / 9743 (1.2%) | 4770 / 97430 (4.9%) | −82.0 | −80.1 | 0.25 |
| JUND SRX150408 | HeLa Uterus | 192 / 9743 (2.0%) | 6022 / 97430 (6.2%) | −81.9 | −80.0 | 0.32 |
| ESR1 SRX5323876 | MCF-7 Breast | 110 / 9743 (1.1%) | 4601 / 97430 (4.7%) | −81.9 | −80.0 | 0.24 |
| FOXA1 SRX3931056 | MCF-7 Breast | 131 / 9743 (1.3%) | 4979 / 97430 (5.1%) | −81.8 | −80.0 | 0.26 |
| FOXA1 SRX9550932 | Prostate cancer Prostate | 268 / 9743 (2.8%) | 7227 / 97430 (7.4%) | −81.8 | −80.0 | 0.37 |
| ESR1 SRX2513518 | MCF-7 Breast | 103 / 9743 (1.1%) | 4466 / 97430 (4.6%) | −81.8 | −80.0 | 0.23 |
| SPI1 SRX5574392 | THP-1 Blood | 421 / 9743 (4.3%) | 9479 / 97430 (9.7%) | −81.8 | −79.9 | 0.44 |
| FOXA1 SRX3923515 | MCF-7 Breast | 122 / 9743 (1.3%) | 4819 / 97430 (4.9%) | −81.8 | −79.9 | 0.25 |
| FOXA1 SRX9550926 | Prostate cancer Prostate | 265 / 9743 (2.7%) | 7174 / 97430 (7.4%) | −81.7 | −79.8 | 0.37 |
| FOXA1 SRX17794420 | 22Rv1 Prostate | 147 / 9743 (1.5%) | 5255 / 97430 (5.4%) | −81.7 | −79.8 | 0.28 |
| FOXA1 SRX1161202 | T-47D Breast | 77 / 9743 (0.8%) | 3957 / 97430 (4.1%) | −81.6 | −79.8 | 0.19 |
| FOXA1 SRX1447316 | MCF-7 Breast | 91 / 9743 (0.9%) | 4229 / 97430 (4.3%) | −81.5 | −79.7 | 0.22 |
| ESR1 SRX5323875 | MCF-7 Breast | 75 / 9743 (0.8%) | 3912 / 97430 (4.0%) | −81.4 | −79.6 | 0.19 |
| HDAC2 SRX190281 | MCF-7 Breast | 194 / 9743 (2.0%) | 6042 / 97430 (6.2%) | −81.4 | −79.6 | 0.32 |
| MAU2 SRX11120893 | MCF-7 Breast | 83 / 9743 (0.9%) | 4073 / 97430 (4.2%) | −81.4 | −79.6 | 0.20 |
| NR3C1 SRX19024866 | MCF-7 Breast | 74 / 9743 (0.8%) | 3892 / 97430 (4.0%) | −81.4 | −79.5 | 0.19 |
| ESR1 SRX11120903 | MCF-7 Breast | 199 / 9743 (2.0%) | 6119 / 97430 (6.3%) | −81.3 | −79.5 | 0.33 |
| FOSL2 SRX10475315 | Hep G2 Liver | 247 / 9743 (2.5%) | 6884 / 97430 (7.1%) | −81.3 | −79.5 | 0.36 |
| ESR1 SRX1161186 | ZR-75-1 Breast | 64 / 9743 (0.7%) | 3684 / 97430 (3.8%) | −81.3 | −79.5 | 0.17 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 144 / 9743 (1.5%) | 5191 / 97430 (5.3%) | −81.2 | −79.4 | 0.28 |
| SMARCC1 SRX11379517 | Liposarcoma, Myxoid Adipocyte | 184 / 9743 (1.9%) | 5861 / 97430 (6.0%) | −81.1 | −79.2 | 0.31 |
| NR3C1 SRX2609665 | HASM2 Lung | 249 / 9743 (2.6%) | 6901 / 97430 (7.1%) | −80.9 | −79.1 | 0.36 |
| SP1 SRX5457222 | Liver Liver | 387 / 9743 (4.0%) | 8953 / 97430 (9.2%) | −80.8 | −79.0 | 0.43 |
| FOXA1 SRX15431000 | T-47D Breast | 181 / 9743 (1.9%) | 5808 / 97430 (6.0%) | −80.8 | −79.0 | 0.31 |
| ASPSCR1 SRX17321275 | ASPS1 Lung | 378 / 9743 (3.9%) | 8827 / 97430 (9.1%) | −80.8 | −79.0 | 0.43 |
| TRP47 SRX4548329 | THP-1 Blood | 1430 / 9743 (14.7%) | 8222 / 97430 (8.4%) | −80.8 | −79.0 | 1.74 |
| JUNB SRX10119384 | MCF 10A Breast | 130 / 9743 (1.3%) | 4926 / 97430 (5.1%) | −80.7 | −78.9 | 0.26 |
| FOXA1 SRX3923511 | MCF-7 Breast | 80 / 9743 (0.8%) | 3990 / 97430 (4.1%) | −80.7 | −78.9 | 0.20 |
| FOXA1 SRX190282 | A549 Lung | 155 / 9743 (1.6%) | 5359 / 97430 (5.5%) | −80.6 | −78.8 | 0.29 |
Showing first 500 of 18034 rows.